Join the Semaglutide group to help and get support from people like you.
Semaglutide News
Another Study Suggests GLP-1 Meds Could Ease Alcoholism
TUESDAY, July 2, 2024 – Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide had 50% to 56% decreased odds for either...
Another Study Suggests GLP-1 Meds Could Ease Alcoholism
TUESDAY, July 2, 2024 – Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide had 50% to 56% decreased odds for either...
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians,...
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure
WEDNESDAY, June 26, 2024 – For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar...
Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder
TUESDAY, June 25, 2024 – Semaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in Nature Communications. ...
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
FRIDAY, JUNE 21, 2024 – Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous...
GLP-1 Meds May Help Extremely Obese Qualify for Weight-Loss Surgery
FRIDAY, June 14, 2024 – Taking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows. Patients with extreme...
GLP-1 RA Use Linked to Lower Quality of Bowel Preparation
THURSDAY, June 13, 2024 – The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing...
Patients Can Take GLP-1 RA Medications Before Surgery
WEDNESDAY, June 12, 2024 – Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications do slow gastric emptying but not by enough to warrant discontinuing medications before surgery, according...
Taking a GLP-1 Medicine? Here's What Experts Say You Should Eat
TUESDAY, June 11, 2024 – Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements for good health, even if they’re eating less. A new set of nutritional r...
Greater Reduction Seen in Mortality With Bariatric Surgery Than GLP-1 RAs
MONDAY, June 10, 2024 – Bariatric metabolic surgery (BMS) is associated with a greater reduction in mortality than glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment among adults with a...
It's Safe to Take GLP-1 Weight Loss Meds Before Surgery: Study
THURSDAY, June 6, 2024 – Despite recent concerns that taking Ozempic, Wegovy or other GLP-1 medications might be unsafe before a surgery, a new review has uncovered no such danger. The issue arose...
Wegovy, Ozempic May Help Curb Alcohol Dependence
TUESDAY, June 4, 2024 – Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so. Researchers at Case...
GLP-1 Weight Loss Meds Might Keep Your Pancreas Healthy
MONDAY, June 3, 2024 – Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says. Up to now, doctors have been cautious about...
Could New Weight-Loss Drugs Be Changing Women's Taste for Sweets?
MONDAY, June 3, 2024 – Ozempic and Wegovy appear to improve people’s sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests. The active ingredient in the w...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Cardiovascular Risk Reduction, Diabetes, Type 2